Qi Zijian

Deputy Chief Physician

Specialized in the treatment of solid malignant tumors, with a total of over a thousand cases treated for 43 tumor types across 8 major categories of advanced malignant solid tumors. Authored the "WABO Therapy Treatment Guidelines and Quality Control Plan", achieving a series of original research outcomes. Established the largest clinical base for international WABO Therapy in China, and is among the first batch of clinical developers and practitioners of WABO Therapy in the country.

Introduction of the expert

He is a specially-appointed expert and associate chief physician at the Advanced Cancer Specialist Clinic of Hainan Chengmei Hospital. He has served as a visiting scholar at Stanford University and San Francisco Hospital in the United States, and was formerly the director of the General Surgery and Oncology Center at Baoji Fifth Peoples Hospital. He was honored as one of the "Top Ten Physicians with Excellent Morality and Skill" at the second Chinese Physicians Day in Baoji. With 37 years of experience in clinical work related to surgical malignant tumors, he introduced the concept of metronomic low-dose chemotherapy immunotherapy (WABO therapy) from the Cancer Center of the University of Arizona in 2016 and conducted clinical practical research. He specializes in the treatment of solid malignant tumors and has treated over a thousand patients with 43 types of tumors across 8 major categories of advanced malignant solid tumors. He has compiled the "WABO Therapy Treatment Standards and Quality Control Plan" and achieved a series of original results. He has established the largest clinical base for WABO therapy in China and is among the first group of clinical developers and practitioners of WABO therapy in the country.

Medical expertise

Specializes in the treatment of solid malignant tumors, with a total of over a thousand cases treated for 43 tumor types across 8 major categories of advanced malignant solid tumors. He has compiled the "WABO Therapy Treatment Standards and Quality Control Plan" and achieved a series of original results. He founded the largest clinical base for international WABO therapy in China and is among the first batch of clinical developers and practitioners of WABO therapy in the country.

Academic Association Appointment

I. Member of the First Special Committee on Malignant Melanoma of the Chinese Anti-Cancer Association

II. Director of the Surgery Branch of the Chinese Ethnic Medicine Association

III. Standing Committee Member of the Health and Wellness Branch of the Chinese Geriatrics and Geriatrics Society

IV. Standing Committee Member of the Hepatobiliary and Pancreatic MDT Professional Committee, Surgical Branch, Shaanxi Provincial Anti-Cancer Association

V. Standing Committee Member of the Surgical Branch of the Shaanxi International Medical Promotion Association

VI. Member of the Breast Cancer Special Committee of the Shaanxi Provincial Anti-Cancer Association.

VII. Member of the Lung Cancer Professional Committee of Shaanxi Provincial Anti-Cancer Association

VIII. Member of the Breast Disease Professional Committee of Shaanxi Provincial Health Care Association

IX. Standing Committee Member of the Minimally Invasive Tumor Specialty Committee of the Shaanxi Provincial Anti-Cancer Association

X. Standing Committee Member of the Tumor Ablation Professional Committee of the Shaanxi Provincial Anti-Cancer Association

XI. member of the Standing Committee of the Melanoma Special Committee of the Shaanxi Provincial Anti-Cancer Association

XII. Standing Committee Member of the Lung Cancer Specialty Committee of the Shaanxi Provincial Geriatrics and Geriatrics Medicine Society

XIII. Standing Committee Member of the Special Committee on Multiple Primary and Unknown Primary Tumors of the Shaanxi Provincial Anti-Cancer Association

XIV. Standing Committee Member of the Traditional Chinese and Western Medicine Minimally Invasive Special Committee of the Shaanxi Provincial Association of Integrated Traditional Chinese and Western Medicine